Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RLAY |
---|---|---|
09:32 ET | 18753 | 4.71 |
09:33 ET | 4700 | 4.62 |
09:35 ET | 550 | 4.6354 |
09:37 ET | 400 | 4.635 |
09:39 ET | 5385 | 4.58 |
09:42 ET | 704 | 4.585 |
09:44 ET | 2532 | 4.59 |
09:46 ET | 6875 | 4.57 |
09:48 ET | 3702 | 4.58 |
09:50 ET | 1009 | 4.5896 |
09:51 ET | 600 | 4.595 |
09:53 ET | 3086 | 4.565 |
09:55 ET | 1356 | 4.565 |
09:57 ET | 900 | 4.58 |
10:00 ET | 1751 | 4.55 |
10:02 ET | 12368 | 4.52 |
10:04 ET | 40961 | 4.51 |
10:06 ET | 2102 | 4.51 |
10:08 ET | 3450 | 4.4903 |
10:09 ET | 4961 | 4.51 |
10:11 ET | 8461 | 4.535 |
10:13 ET | 401 | 4.54 |
10:15 ET | 15024 | 4.53 |
10:18 ET | 2110 | 4.568 |
10:20 ET | 1300 | 4.58 |
10:22 ET | 6865 | 4.59 |
10:24 ET | 1692 | 4.59 |
10:26 ET | 300 | 4.585 |
10:27 ET | 2149 | 4.56 |
10:29 ET | 4082 | 4.54 |
10:31 ET | 863 | 4.5365 |
10:33 ET | 2751 | 4.56 |
10:36 ET | 3723 | 4.5625 |
10:38 ET | 18230 | 4.56 |
10:40 ET | 500 | 4.55 |
10:42 ET | 2796 | 4.56 |
10:44 ET | 2932 | 4.5775 |
10:45 ET | 8114 | 4.575 |
10:47 ET | 2206 | 4.59 |
10:49 ET | 1561 | 4.59 |
10:51 ET | 5372 | 4.61 |
10:54 ET | 2672 | 4.605 |
10:56 ET | 2639 | 4.62 |
10:58 ET | 1400 | 4.635 |
11:00 ET | 4837 | 4.615 |
11:02 ET | 8744 | 4.61 |
11:03 ET | 4906 | 4.599 |
11:05 ET | 4192 | 4.6 |
11:07 ET | 509 | 4.6 |
11:09 ET | 5749 | 4.58 |
11:12 ET | 2018 | 4.58 |
11:14 ET | 3381 | 4.59 |
11:16 ET | 2921 | 4.61 |
11:18 ET | 11236 | 4.6 |
11:20 ET | 711 | 4.6 |
11:21 ET | 3838 | 4.6 |
11:23 ET | 4811 | 4.59 |
11:25 ET | 5194 | 4.61 |
11:27 ET | 5258 | 4.61 |
11:30 ET | 7020 | 4.615 |
11:32 ET | 8208 | 4.64 |
11:34 ET | 7031 | 4.65 |
11:36 ET | 4068 | 4.7 |
11:38 ET | 9006 | 4.67 |
11:39 ET | 1389 | 4.7 |
11:41 ET | 5149 | 4.67 |
11:43 ET | 1953 | 4.675 |
11:45 ET | 29927 | 4.67 |
11:48 ET | 5907 | 4.6601 |
11:50 ET | 3661 | 4.66 |
11:52 ET | 6146 | 4.685 |
11:54 ET | 9883 | 4.685 |
11:56 ET | 12477 | 4.665 |
11:57 ET | 3252 | 4.665 |
11:59 ET | 3934 | 4.665 |
12:01 ET | 942 | 4.665 |
12:03 ET | 6064 | 4.6501 |
12:06 ET | 3538 | 4.635 |
12:08 ET | 20720 | 4.62 |
12:10 ET | 8687 | 4.655 |
12:12 ET | 1806 | 4.655 |
12:14 ET | 2645 | 4.645 |
12:15 ET | 3758 | 4.645 |
12:17 ET | 10421 | 4.655 |
12:19 ET | 2453 | 4.655 |
12:21 ET | 5616 | 4.655 |
12:24 ET | 617 | 4.6545 |
12:26 ET | 2450 | 4.655 |
12:28 ET | 6391 | 4.6606 |
12:30 ET | 4042 | 4.665 |
12:32 ET | 4365 | 4.675 |
12:33 ET | 7056 | 4.67 |
12:35 ET | 1334 | 4.665 |
12:37 ET | 5402 | 4.665 |
12:39 ET | 4665 | 4.6642 |
12:42 ET | 15615 | 4.67 |
12:44 ET | 18675 | 4.675 |
12:46 ET | 12474 | 4.705 |
12:48 ET | 6402 | 4.715 |
12:50 ET | 3788 | 4.725 |
12:51 ET | 2277 | 4.72 |
12:53 ET | 2300 | 4.74 |
12:55 ET | 300 | 4.74 |
12:57 ET | 2763 | 4.735 |
01:00 ET | 5260 | 4.725 |
01:02 ET | 8958 | 4.7201 |
01:04 ET | 3568 | 4.7288 |
01:06 ET | 1270 | 4.725 |
01:08 ET | 9491 | 4.695 |
01:09 ET | 1655 | 4.72 |
01:11 ET | 3774 | 4.7399 |
01:13 ET | 4823 | 4.7258 |
01:15 ET | 6033 | 4.725 |
01:18 ET | 4536 | 4.735 |
01:20 ET | 3015 | 4.735 |
01:22 ET | 1529 | 4.7357 |
01:24 ET | 3329 | 4.74 |
01:26 ET | 22393 | 4.72 |
01:27 ET | 3089 | 4.719075 |
01:29 ET | 3736 | 4.705 |
01:31 ET | 7503 | 4.705 |
01:33 ET | 8112 | 4.705 |
01:36 ET | 1485 | 4.705 |
01:38 ET | 11556 | 4.705 |
01:40 ET | 3929 | 4.69 |
01:42 ET | 4857 | 4.685 |
01:44 ET | 9676 | 4.6897 |
01:45 ET | 4825 | 4.7 |
01:47 ET | 1811 | 4.695 |
01:49 ET | 8184 | 4.6925 |
01:51 ET | 727 | 4.695 |
01:54 ET | 4658 | 4.68 |
01:56 ET | 7291 | 4.695 |
01:58 ET | 2397 | 4.695 |
02:00 ET | 3752 | 4.705 |
02:02 ET | 8282 | 4.7 |
02:03 ET | 1660 | 4.695 |
02:05 ET | 900 | 4.69 |
02:07 ET | 691 | 4.69 |
02:09 ET | 1376 | 4.685 |
02:12 ET | 8489 | 4.655 |
02:14 ET | 2096 | 4.655 |
02:16 ET | 12406 | 4.655 |
02:18 ET | 7950 | 4.655 |
02:20 ET | 1447 | 4.645 |
02:21 ET | 238 | 4.645 |
02:23 ET | 4907 | 4.64 |
02:25 ET | 5875 | 4.645 |
02:27 ET | 3973 | 4.645 |
02:30 ET | 2918 | 4.65 |
02:32 ET | 5434 | 4.65 |
02:34 ET | 16751 | 4.66 |
02:36 ET | 3827 | 4.655 |
02:38 ET | 1435 | 4.655 |
02:39 ET | 509 | 4.655 |
02:41 ET | 506 | 4.655 |
02:43 ET | 5344 | 4.6471 |
02:45 ET | 9100 | 4.645 |
02:48 ET | 8300 | 4.646 |
02:50 ET | 10374 | 4.635 |
02:52 ET | 2560 | 4.645 |
02:54 ET | 990 | 4.645 |
02:56 ET | 6845 | 4.64 |
02:57 ET | 615 | 4.64 |
02:59 ET | 3930 | 4.6406 |
03:01 ET | 3251 | 4.645 |
03:03 ET | 9628 | 4.645 |
03:06 ET | 2537 | 4.63 |
03:08 ET | 4750 | 4.65 |
03:10 ET | 3924 | 4.65 |
03:12 ET | 500 | 4.65 |
03:14 ET | 6733 | 4.65 |
03:15 ET | 894 | 4.645 |
03:17 ET | 10870 | 4.655 |
03:19 ET | 12932 | 4.655 |
03:21 ET | 31385 | 4.655 |
03:24 ET | 18841 | 4.655 |
03:26 ET | 10925 | 4.655 |
03:28 ET | 94717 | 4.665 |
03:30 ET | 11896 | 4.655 |
03:32 ET | 1238 | 4.65 |
03:33 ET | 18421 | 4.655 |
03:35 ET | 11034 | 4.642 |
03:37 ET | 7090 | 4.635 |
03:39 ET | 8236 | 4.625 |
03:42 ET | 5045 | 4.63 |
03:44 ET | 4904 | 4.625 |
03:46 ET | 12957 | 4.625 |
03:48 ET | 5295 | 4.625 |
03:50 ET | 14878 | 4.615 |
03:51 ET | 14366 | 4.615 |
03:53 ET | 5985 | 4.615 |
03:55 ET | 41811 | 4.625 |
03:57 ET | 42729 | 4.615 |
04:00 ET | 231431 | 4.64 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Relay Therapeutics Inc | 776.7M | -1.8x | --- |
Capricor Therapeutics Inc | 808.9M | -16.7x | --- |
Abcellera Biologics Inc | 803.4M | -4.5x | --- |
Tyra Biosciences Inc | 777.3M | -9.6x | --- |
Kura Oncology Inc | 782.3M | -4.3x | --- |
Autolus Therapeutics PLC | 755.7M | -2.4x | --- |
Relay Therapeutics Inc. is a clinical-stage precision medicine company. The Company is focused on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The Company’s Dynamo platform integrates an array of computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. The Company’s lead product candidates, such as RLY-2608, Lirafugratinib (RLY-4008), and Migoprotafib (GDC-1971). RLY-2608 is an allosteric, pan-mutant and isoform-selective phosphoinostide 3 kinase alphas (PI3Kα), inhibitor. RLY-4008, is a potent, selective, and oral small molecule inhibitor of FGFR2, a receptor tyrosine kinase that is frequently altered in certain cancers. GDC-1971 is an inhibitor of Src homology region 2 domain-containing phosphatase-2 (SHP2), as a monotherapy in patients with advanced or metastatic solid tumors.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $776.7M |
---|---|
Revenue (TTM) | $10.0M |
Shares Outstanding | 167.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.62 |
EPS | $-2.61 |
Book Value | $5.90 |
P/E Ratio | -1.8x |
Price/Sales (TTM) | 77.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,794.57% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.